This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:translations:norwegian [06.11.2018] – [Vitenskapelig grunnlag for behandlingen] sallieq | home:translations:norwegian [05.10.2019] – [Data] sallieq | ||
---|---|---|---|
Line 337: | Line 337: | ||
Pasienter som slutter med olmesartan utsetter helbredelsesprosessen. | Pasienter som slutter med olmesartan utsetter helbredelsesprosessen. | ||
+ | ===== Data ===== | ||
+ | |||
+ | [[home: | ||
+ | |||
+ | [[home: | ||
+ | |||
+ | ==== Response in 5 diagnoses ==== | ||
+ | |||
+ | | ||
+ | |||
+ | SUCCESS RATES: Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91% | ||
+ | |||
+ | Sarcoidosis success 75.8% | ||
+ | |||
+ | Chronic Fatigue Syndrome success 60.1% | ||
+ | |||
+ | Lyme disease success 66.9% | ||
+ | |||
+ | Rheumatoid arthritis success 69.2% | ||
+ | |||
+ | Fibromyalgia success 64.2% | ||
+ | |||
+ | All Other Th1 disease success 59.8% | ||
==== Diverse av interesse for skandinaviske lesere ==== | ==== Diverse av interesse for skandinaviske lesere ==== | ||